Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China

Effectiveness of Subcutaneous Tumor Necrosis Factor Inhibitors in Patients With Ankylosing Spondylitis: A Real-World Prospective Observational Cohort Study in China

Objective: This prospective observational study investigated the efficacy of tumor necrosis factor inhibitors (TNFis) on disease activity, physical functionality, and mobility in patients with ankylosing spondylitis (AS) in a real-world setting.Methods: The Chinese Ankylosing Spondylitis Prospective...

Full description

Bibliographic Details
Main Authors: Xiaojian Ji, Yiwen Wang, Zhengyuan Hu, Yingpei Ma, Siliang Man, Kunpeng Li, Yanyan Wang, Jian Zhu, Jianglin Zhang, Feng Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Pharmacology
Subjects:
tumor necrosis factor
ankylosing spondylitis disease activity
real-world study
adalimumab
biosimilar etanercept
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.01476/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.01476/full

Similar Items